Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+145.0%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+145.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
14.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$182.38M+398.9%
2024$36.55M+316.3%
2023$8.78M-29.2%
2022$12.40M-
2021$0.00+100.0%
2020$-1.93M-328.0%
2019$-450000.00-110.3%
2018$-214000.00-89.4%
2017$-113000.00-